Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-119 |
Sentence |
denotes |
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: |
T2 |
120-159 |
Sentence |
denotes |
A Single-Center Study in Madrid, Spain. |
T3 |
160-171 |
Sentence |
denotes |
BACKGROUND: |
T4 |
172-271 |
Sentence |
denotes |
There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD). |
T5 |
272-391 |
Sentence |
denotes |
Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD. |
T6 |
392-400 |
Sentence |
denotes |
METHODS: |
T7 |
401-448 |
Sentence |
denotes |
This is a cross-sectional, observational study. |
T8 |
449-642 |
Sentence |
denotes |
We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition. |
T9 |
643-725 |
Sentence |
denotes |
Data were obtained by patient electronical medical records and by phone interview. |
T10 |
726-734 |
Sentence |
denotes |
RESULTS: |
T11 |
735-934 |
Sentence |
denotes |
Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection. |
T12 |
935-1077 |
Sentence |
denotes |
Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities. |
T13 |
1078-1176 |
Sentence |
denotes |
Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%). |
T14 |
1177-1256 |
Sentence |
denotes |
One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection. |
T15 |
1257-1351 |
Sentence |
denotes |
Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19. |
T16 |
1352-1425 |
Sentence |
denotes |
Most of the patients had mild disease (79.3%), and 1 patient died (1.2%). |
T17 |
1426-1675 |
Sentence |
denotes |
In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course. |
T18 |
1676-1722 |
Sentence |
denotes |
Immunosuppression was not related to severity. |
T19 |
1723-1790 |
Sentence |
denotes |
CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare. |
T20 |
1791-1842 |
Sentence |
denotes |
Dyspnea is associated with a more severe infection. |
T21 |
1843-2030 |
Sentence |
denotes |
Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups. |